Need professional-grade analysis? Visit stockanalysis.com
$1.15T
14.81
2,253
0.57%
Price Chart
Risk-Adjusted Performance
Chong Kun Dang Pharmaceutical (185750) Price Performance
Chong Kun Dang Pharmaceutical (185750) trades on KO in KRW. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at KRW87300.00, down 0.11% from the previous close.
Over the past year, 185750 has traded between a low of KRW77300.00 and a high of KRW97700.00. The stock has gained 12.2% over this period. It is currently 10.6% below its 52-week high.
Chong Kun Dang Pharmaceutical has a market capitalization of $1.15T, with a price-to-earnings ratio of 14.81 and a dividend yield of 0.57%.
About Chong Kun Dang Pharmaceutical
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Company Info
- Sector
- Healthcare
- Exchange
- KO
- Currency
- KRW
- Country
- South Korea
Financial Metrics
- Revenue (TTM)
- $860.04B
- EBITDA
- $99.68B
- Profit Margin
- 6.09%
- EPS (TTM)
- N/A
- Book Value
- 1003754.62
Technical Indicators
- 52 Week High
- ₩106,800.00
- 52 Week Low
- ₩75,600.00
- 50 Day MA
- ₩89,304.00
- 200 Day MA
- ₩85,133.00
- Beta
- -0.43
Valuation
- Trailing P/E
- 14.81
- Forward P/E
- N/A
- Price/Sales
- 1.33
- Price/Book
- 1.16
- Enterprise Value
- $1.18T